Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,247,004
+$826,755 QoQ
Shares Held
88,590
-4.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.33%
of 13F equity value
Holder Rank
#239
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HEADINVEST, LLC holds $15,409,722 across 8 Drug Manufacturers - General names. NVO ranks #1 (27.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
This page
|
88,590 | $4,247,004 | |
| 2 | NVS |
Novartis AG
|
15,391 | $2,412,077 | |
| 3 | ABBV |
AbbVie Inc.
|
9,300 | $2,340,252 | |
| 4 | LLY |
ELI LILLY & Co
|
1,634 | $1,959,868 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,769 | $1,897,816 | |
| 6 | JNJ |
Johnson & Johnson
|
7,126 | $1,809,790 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,791 | $391,297 | |
| 8 | AMGN |
Amgen Inc
|
971 | $351,618 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,247,004 | 88,590 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,420,249 | 93,068 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,380,458 | 105,748 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $6,273,921 | 113,064 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,074,580 | 116,989 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,914,493 | 113,976 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,997,846 | 116,227 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $14,258,275 | 119,747 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $17,788,544 | 124,622 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $16,529,188 | 128,732 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $14,132,407 | 136,611 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $12,642,296 | 139,018 | Shares | Sole | 2023-12-11 | |
| 2023-06-30 | $11,347,357 | 70,119 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $12,144,132 | 76,311 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $11,312,799 | 83,588 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,599,164 | 86,311 | Shares | Sole | 2022-12-28 | |
| 2022-06-30 | $9,779,765 | 87,766 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,897,664 | 89,128 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $10,169,040 | 90,795 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,010,250 | 93,847 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $7,933,521 | 94,706 | Shares | Sole | 2021-08-30 | |
| 2021-03-31 | $6,408,203 | 95,049 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $6,690,861 | 95,789 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,420,122 | 92,469 | Shares | Sole | 2020-11-24 | |
| 2020-06-30 | $6,132,463 | 93,654 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $5,699,194 | 94,671 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||